Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Righi

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|February 27, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in ChondrosarcomaAgnieszka E Zając, Piotr Rutkowski, Anna Szumera-Ciećkiewicz, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 7, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcomaMaria Cristina Manara, Francesca Bruzzese, Laura Formentini, et al.
Genes, Chromosomes & Cancer|April 7, 2017
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcomaMilena Urbini, Annalisa Astolfi, Maria Abbondanza Pantaleo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2021
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed casesJosephine K Dermawan, Elizabeth M Azzato, Steven D Billings, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Pathology, Research and Practice|July 30, 2021
Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative studyIsidro Machado, Julia Cruz, Alberto Righi, et al.
Nature Medicine|January 16, 2018
Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Nature Medicine|April 11, 2018
Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|February 27, 2026
Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in ChondrosarcomaAgnieszka E Zając, Piotr Rutkowski, Anna Szumera-Ciećkiewicz, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 7, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcomaMaria Cristina Manara, Francesca Bruzzese, Laura Formentini, et al.
Genes, Chromosomes & Cancer|April 7, 2017
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcomaMilena Urbini, Annalisa Astolfi, Maria Abbondanza Pantaleo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2021
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed casesJosephine K Dermawan, Elizabeth M Azzato, Steven D Billings, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Pathology, Research and Practice|July 30, 2021
Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative studyIsidro Machado, Julia Cruz, Alberto Righi, et al.
Nature Medicine|January 16, 2018
Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Nature Medicine|April 11, 2018
Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competenceJames J Morrow, Ian Bayles, Alister P W Funnell, et al.
Pageof 20